Estimating The Economic Consequences Of An Increased Medication Compliance Due To A Potential Improvement Of The Inhaler Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Patients With Copd In Spain
Abstract
Authors
J Darba G Ramírez S Gómez A Bijedic R Sánchez-de la Rosa L Garcia-Bujalance S Torvinen